Humacyte, Inc. (HUMA) Reports In-Line Q3 EPS

Humacyte, Inc. (NASDAQ: HUMA) reported Q3 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• DigitalOcean (DOCN) Reiterated at Overweight by Cantor Fitzgerald on Q2 Pre-Announcement
• UBS Reiterates Neutral Rating on Carter's (CRI)